Decoding IgE Fc receptors

Immunologic Research

Volumn 37, Issue 1, 2007, Pages 1-16

  Zhang, Ming ^a   Murphy, Richard F ^a   Agrawal, Devendra K ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Allergy; Anti IgE therapy; CD23; Fc RI; Fc RII; IgE receptors; Immunoglobulins; ITAMs; ITIMs; Lipid raft segregation; RabGEF1

Indexed keywords

ANTIALLERGIC AGENT; ANTIHISTAMINIC AGENT; BRONCHODILATING AGENT; CD23 ANTIGEN; CORTICOSTEROID; FC RECEPTOR; FC RECEPTOR ANTIBODY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN E RECEPTOR; IMMUNOGLOBULIN F(AB) FRAGMENT; LUMILIXIMAB; MONOMER; OMALIZUMAB; PROTEIN KINASE LYN; PROTEIN KINASE SYK; STEROID; UNCLASSIFIED DRUG;

ALLERGIC DISEASE; ALLERGIC RHINITIS; ASTHMA; BINDING AFFINITY; CELL FUNCTION; CELLULAR DISTRIBUTION; CHRONIC URTICARIA; CROSS LINKING; DISEASE EXACERBATION; DOSE TIME EFFECT RELATION; DRUG RECEPTOR BINDING; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; IMMUNOMODULATION; LIPID ANALYSIS; LIPID RAFT; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITY OF LIFE; REGULATORY MECHANISM; RESPIRATORY TRACT DISEASE; REVIEW; SIGNAL TRANSDUCTION;

GENE EXPRESSION REGULATION; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; RECEPTORS, FC; RECEPTORS, IGE; SIGNAL TRANSDUCTION;

EID: 34248367985     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02686092     Document Type: Review

References (45)

1. Daeron M: Fc receptor biology. Annu Rev Immunol 1997; 15:203-234.
2. Nadler MJ, Matthews SA, Turner H, Kinet JP: Signal transduction by the high-affinity immunoglobulin E receptor FcεRI: coupling form to function. Adv Immunol 2001; 76:325-355.
3. Parravicini V, Gadina M, Kovarova M, et al: Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation. Nat Immunol 2002; 3:741-748.
4. Galli SJ, Kalesinikoff J, Grimbaldeston MA, Piliponsky AM, Williams CM, Tsai M: Mast cells as "tunable" effectors and immunoregulatory cells: recent advances. Annu Rev Immunol 2005; 23:749-786.
5. Novak N, Kraft S, Bieber T: IgE receptors. Curr Opin Immunol 2001; 13:721-726.
6. Mukai K, Matsuoka K, Taya C, et al: Basophils play a critical role in the development of IgE-mediated chronic allergic inflammation independently of T cells and mast cells. Immunity 2005; 23:191-202.
7. Schroeder JT, Bieneman AP, Xiao H, et al: TLR9- and FcepsilonRI-mediated responses oppose one another in plasmacytoid dendritic cells by down-regulating receptor expression. J Immunol 2005; 175:5724-5731.
8. Gounni AS, Wellemans V, Yang J, et al: Human airway smooth muscle cells express the high affinity receptor for IgE (Fc epsilon RI): a critical role of Fc epsilon RI in human airway smooth muscle cell function. J Immunol 2005; 175:2613-2621.
9. Donnadieu E, Jouvin MH, Rana S, et al: Competing functions encoded in the allrgy-associated F(c)epsilon-RIbeta gene. Immunity 2003; 18:665-674.
10. Fiebiger E, Tortorella D, Jouvin MH, Kinet JP, Ploegh HL: Cotranslational endoplasmic reticulum assembly of Fc{varepsilon}RI controls the formation of functional IgE-binding receptors. J Exp Med 2005; 201:267-277.
11. Nishiyama C, Akizawa Y, Nishiyama M, et al: Polymorphisms in the Fc epsilon RI beta promoter region affecting transcription activity: a possible promoter-dependent mechanism for association between Fc epsilon RI beta and atopy. J Immunol 2004; 173:6458-6464.
12. Hasegawa M, Nishiyama C, Nishiyama M, et al: A novel -66T/C polymorphism in Fc epsilon RI alpha-chain promoter affecting the transcription activity: possible relationship to allergic diseases. J Immunol 2003; 171:1927-1933.
13. Bobrzynski T, Fux M, Vogel M, Stadler MB, Stadler BM, Miescher SM: A high-affinity natural autoantibody from human cord blood defines a physiologically relevant epitope on the FcepsilonRIalpha. J Immunol 2005; 175:6589-6596.
14. Bruhns P, Fremont S, Daeron M: Regulation of allergy by Fc receptors. Curr Opin Immunol 2005; 17:662-669.
15. Kawakami T, Galli SJ: Regulation of mast-cell and basophile function and survival by IgE. Nat Rev Immunol 2002; 10:773-786.
16. Kitaura J, Xiao W, Maeda-Yamamoto M, Kawakami Y, Lowell CA, Kawakami T: Early divergence of Fc epsilon receptor I signals for receptor up-regulation and internalization from degranulation, cytokine production, and survival. J Immunol 2004; 173:4317-4323.
17. Lam V, Kalesnikoff J, Lee CW, et al: IgE alone stimulates mast cell adhesion to fibronectin via pathways similar to those used by IgE + antigen but distinct from those used by Steel factor. Blood 2003; 102:1405-1413.
18. Kitaura J, Kinoshita T, Matsumoto M, et al: IgE- and IgE+Ag-mediated mast cell migration in an autocrine/paracrine fashion. Blood 2005; 105:3222-3229.
19. Kitaura J, Song J, Tsai M, et al: Evidence that IgE molecules mediate a spectrum of effects on mast cell survival and activation via aggregation of the FcepsilonRI. Proc Natl Acad Sci USA 2003; 100:12911-12916.
20. James LC, Roversi P, Tawfik DS: Antibody multispecificity mediated by conformational diversity. Science 2003; 299:1362-1367.
21. Schweitzer-Stenner R, Pecht I: Death of a dogma or enforcing the artificial: monomeric IgE binding may initiate mast cell response by inducing its receptor aggregation. J Immunol 2005; 174:4461-4464.
22. Holowka D, Gosse JA, Hammond AT, et al: Lipid segregation and IgE receptor signaling: a decade of progress. Biochim Biophys Acta 2005; 1746:252-259.
23. Young RM, Zheng X, Holowka D, Baird B: Reconstitution of regulated phosphorylation of FcepsilonRI by a lipid raft-excluded protein-tyrosine phosphatase. J Biol Chem 2005; 280:1230-1235.
24. Gosse JA, Wagenknecht-Wiesner A, Holowka D, Baird B: Transmembrane sequences are determinants of immunoreceptor signaling. J Immunol 2005; 175:2123-2131.
25. Wu M, Holowka D, Craighead HG, Baird B: Visualization of plasma membrane compartmentalization with patterned lipid bilayers. Proc Natl Acad Sci USA 2004; 101:13798-13803.
26. Lesourne R, Fridman WH, Daeron M: Dynamic interactions of Fc gamma receptor IIB with filamin-bound SHIP1 amplify filamentous actin-dependent negative regulation of Fc epsilon receptor I signaling. J Immunol 2005; 174:1365-1373.
27. Larson DR, Gosse JA, Holowka DA, Baird BA, Webb WW: Temporally resolved interactions between antigen-stimulated IgE receptors and Lyn kinase on living cells. J Cell Biol 2005; 171:527-536.
28. Gimborn K, Lessmann E, Kuppig S, Krystal G, Huber M: SHIP down-regulates FcepsilonR1-induced degranulation at supraoptimal IgE or antigen levels. J Immunol 2005; 174:507-516.
29. Xiao W, Nishimoto H, Hong H, et al: Positive and negative regulation of mast cell activation by Lyn via the FcepsilonRI. J Immunol 2005; 175:6885-6892.
30. Furumoto Y, Nunomura S, Terada T, Rivera J, Ra C: The FcepsilonRIbeta immunoreceptor tyrosine-based activation motif exerts inhibitory control on MAPK and IkappaB kinase phosphorylation and mast cell cytokine production. J Biol Chem 2004; 279:49177-49187.
31. Xu Y, Harder KW, Huntington ND, Hibbs ML, Tarlinton DM: Lyn tyrosine kinase: accentuating the positive and the negative. Immunity 2005; 22:9-18.
32. Hernandez-Hansen V, Smith AJ, Surviladze Z, et al: Dysregulated FcepsilonRI signaling and altered Fyn and SHIP activities in Lyn-deficient mast cells. J Immunol 2004; 173:100-112.
33. Odom, Gomez G, Kovarova M, et al: Negative regulation of immunoglobulin E-dependent allergic responses by Lyn kinase. J Exp Med 2004; 199:1491-1502.
34. Simon M, Vanes L, Geahlen RL, Tybulewicz VL: Distinct roles for the linker region tyrosines of Syk in FcepsilonRI signaling in primary mast cells. J Biol Chem 2005; 280:4510-4517.
35. Kettner A, Kumar L, Anton IM, et al: WIP regulates signaling via the high affinity receptor for immunoglobulin E in mast cells. J Exp Med 2004; 199:357-368.
36. Pasquier B, Launay P, Kanamaru Y, et al: Identification of FcalphaRI as an inhibitory receptor that controls inflammation: dual role of FcRgamma ITAM. Immunity 2005; 22:31-42.
37. Tam SY, Tsai M, Snouwaert JN, et al: RabGEF1 is a negative regulator of mast cell activation and skin inflammation. Nat Immunol 2004; 5:844-852.
38. D'Amato G: Role of anti-IgE monoclonal antibody (omalizumab) in the treatment of bronchial asthma and allergic respiratory diseases. Eur J Pharmacol 2006; 533:302-307.
39. Bousquet J, Cabrera P, Berkman N, et al: The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma. Allergy 2005; 60:302-308.
40. Zhu D, Kepley CL, Zhang M, Zhang K, Saxon A: A novel human immunoglobulin Fc gamma Fc epsilon bifunctional fusion protein inhibits Fc epsilon RI-mediated degranulation. Nat Med 2002; 8:518-521.
41. Tam SW, Demissie S, Thomas D, DaeronM: A bispecific antibody against human IgE and human FcgammaRII that inhibits antigen-induced histamine release by human mast cells and basophils. Allergy 2004; 59:772-780.
42. Hibbert RG, Teriete P, Grundy GJ, et al: The structure of human CD23 and its interactions with IgE and CD21. J Exp Med 2005; 202:751-760.
43. Puccetti A, Bason C, Simeoni S, et al: In chronic idiopathic urticaria autoantibodies against Fc epsilonRII/CD23 induce histamine release via eosinophil activation. Clin Exp Allergy 2005; 35:1599-1607.
44. Getahun A, Hjelm F, Heyman B: IgE enhances antibody and T cell responses in vivo via CD23+ B cells. J Immunol 2005; 175:1473-1482.
45. Poole JA, Meng J, Reff M, Spellman MC, Rosenwasser LJ: Anti-CD23 monoclonal antibody, lumiliximab, inhibited allergen-induced responses in antigen-presenting cells and T cells from atopic subjects. J Allergy Clin Immunol 2005; 116:780-788.